USNU Financials 07/16/2014 10:57:14 U.S. NeuroSur

USNU Financials 07/16/2014 10:57:14
U.S. NeuroSurgical, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - 1,956 2,060 1,916
Cost of Revenue - 675 884 603
Gross Profit - 1,281 1,176 1,313
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 994 1,034 947 979
Non-Recurring Items - - - -
Other - - - -
Operating Income (994) 247 229 334
Income From Continuing Operations
Add'l Income/Expense Items 11 959 12 5
Earnings Before Interest and Tax (1,014) 1,290 267 299
Interest Expense 15 199 177 359
Earnings Before Tax (1,029) 1,091 90 (60)
Income Tax (362) 362 - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary (31) 84 26 (40)
Net Income Cont. Operations (698) 813 90 (60)
Non Recurring Events
Discontinued Operations - - (61) 529
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (667) 729 29 469
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (667) 729 29 469